ORIGINAL RESEARCH article
Front. Microbiol.
Sec. Microorganisms in Vertebrate Digestive Systems
This article is part of the Research TopicRodent Model Organisms: Therapeutic Treatments and Drugs Interaction with the Gut Microbiome, Volume IIView all 19 articles
Miniature Rose Alleviates Inflammatory Bowel Disease in Mice by Modulating Gut Microbiota, Inhibiting TLR4, Enhancing Tight Junction Proteins, and Promoting Metabolism
Provisionally accepted
Jiaying Wu
Xuwen Mao*- Xinjiang Medical University, Ürümqi, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Introduction: Inflammatory bowel disease (IBD) is a chronic, relapsing inflammatory disorder of the gastrointestinal tract. Its pathogenesis is complex and not fully understood, so it remains incurable. Traditional Chinese medicine (TCM) attracts attention as a potential option. It offers multi-target actions. This study investigated the protective effects of an aqueous extract of Miniature Rose (MR), a medicinal plant from Xinjiang, in a dextran sulfate sodium (DSS)-induced murine model of IBD. We focused on gut microbiota, intestinal barrier integrity, and metabolic homeostasis. Methods: IBD was induced in mice by DSS, followed by intervention with different doses of aqueous MR extract. A multi-faceted approach incorporating 16S rRNA sequencing, non-targeted metabolomics, immunohistochemistry, and ELISA was used to evaluate the effects of MR on gut microbiota composition, fecal metabolic profiles, intestinal barrier protein expression, and the expression of the inflammatory proteins TLR4 and TLR9. Results: Treatment with aqueous MR extract markedly alleviated DSS-induced colitis. MR improved intestinal barrier integrity by upregulating the tight junction proteins Occludin (OCC) and Zonula Occludens-1 (ZO-1), while concurrently downregulating TLR4 and TLR9. MR administration also markedly modulated the gut microbiota, increasing the relative abundance of beneficial genera (Bacteroides and Alloprevotella) and decreasing the abundance of the pathobiont Erysipelatoclostridium. In addition, MR mitigated the metabolic dysregulation observed in DSS-induced colitis. Conclusion: MR ameliorates DSS-induced colitis through a multifaceted mechanism that involves coordinated regulation of the gut microbiota, restoration of the intestinal barrier, inhibition of inflammatory protein expression, and correction of metabolic dysregulation. These findings highlight the potential of MR as a multi-target therapeutic candidate and provide an experimental basis for its further preclinical and clinical evaluation in IBD.
Keywords: inflammatory bowel disease, Gut Microbiota, Metabolomics, Miniature rose aqueousextract, intestinal barrier
Received: 09 Oct 2025; Accepted: 30 Nov 2025.
Copyright: © 2025 Wu and Mao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Xuwen Mao
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.